Christopher Harris is a seasoned Network Director at ChenMed, where he leverages over 14 years of extensive experience in network development and management within the healthcare sector. In his current role, he is responsible for overseeing the financial and medical cost performance of more than...
Christopher Harris is a seasoned Network Director at ChenMed, where he leverages over 14 years of extensive experience in network development and management within the healthcare sector. In his current role, he is responsible for overseeing the financial and medical cost performance of more than 20 primary care clinics, serving a diverse patient population of over 30,000 Medicare beneficiaries across Texas, the Midwest, and Central Florida. His strategic leadership has been instrumental in achieving a remarkable 6.5% reduction in costs, underscoring his commitment to enhancing operational efficiency and patient care.
A key aspect of Christopher's role involves cultivating a robust network of specialists, facilities, vendors, and ancillary providers to facilitate seamless PCP referrals. This initiative has resulted in an impressive 11% increase in provider satisfaction, demonstrating his ability to foster collaborative relationships that enhance the overall healthcare experience for patients. His expertise in network optimization, credentialing, and contract negotiation allows him to navigate the complexities of Medicaid and Medicaid Managed Care effectively, ensuring compliance with HIPAA regulations while maximizing the value delivered to patients.
Christopher's strategic planning skills are complemented by his hands-on approach to physician coaching and hospital contracting, enabling him to drive initiatives that align with ChenMed's mission of providing high-quality, patient-centered care. As he continues to chart the course for network development in his regions, Christopher remains dedicated to improving health outcomes and delivering substantial cost savings, solidifying his reputation as a leader in the healthcare industry.